Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amide Reduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel reduction method for dexpramipexole dihydrochloride. High purity, mild conditions, cost-effective API manufacturing solution.
Patent CN110818576B reveals a novel rare earth catalyzed synthesis of secondary amines. High yield, mild conditions, and cost-effective supply chain solutions for pharma.
Advanced two-step synthesis of ethylmethylcarbamoyl chloride via amide reduction. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel amide-mediated route for Bempedoic Acid reduces steps and improves purity. Ideal for reliable pharmaceutical intermediate suppliers seeking cost-effective scale-up.
Patent CN111747879B details a large-scale synthesis of Erexib avoiding unstable intermediates. Discover cost-effective manufacturing and supply chain advantages.
Patent CN112920053A reveals a safer, high-yield route for chiral amines used in asthma and cancer drugs, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN112920053B reveals a scalable, high-purity route for chiral amines used in asthma and oncology APIs, offering significant cost and safety advantages.